CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang
Cancer Research and Treatment. 2017;49(3):807-815.   Published online 2017 January 18    DOI: https://doi.org/10.4143/crt.2016.326

Excel Download

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
Cancer Research and Treatment. 2017;49(3):807-815   Crossref logo
Link1 Link2 Link3

Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients
Annals of Oncology. 2018;29:v29   Crossref logo
Link1 Link2 Link3

Comparison between Fluoropyrimidine-Cisplatin and Gemcitabine-Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Meta-Analysis
Oncology Research and Treatment. 2020;43(9):460-469   Crossref logo
Link1 Link2

First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”
Cancer Treatment and Research Communications. 2021;27:100335   Crossref logo
Link1 Link2

CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience
Medical Oncology. 2016;33(9):   Crossref logo
Link1 Link2 Link3

The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer
Disease Markers. 2019;2019:1-8   Crossref logo
Link1 Link2 Link3

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
Cancer Chemotherapy and Pharmacology. 2008;62(5):849-855   Crossref logo
Link1 Link2 Link3

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
Asia-Pacific Journal of Clinical Oncology. 2010;6(2):98-105   Crossref logo
Link1

Sa1370 - Ca19-9 Nadir Within the First 12 Weeks of Chemotherapy Predicts Overall Survival in Patients with Advanced Pancreatic Cancer
Gastroenterology. 2018;154(6):S-281-S-282   Crossref logo
Link1 Link2

Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer
Asia-Pacific Journal of Clinical Oncology. 2016;13(1):13-20   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.